MedTech Dive January 3, 2025
Susan Kelly

Olympus advised providers to stop using an endoscope accessory due to an infection risk linked to 120 injuries and one death.

In the final days of 2024, the Food and Drug Administration notified the public of safety issues involving medical devices from Olympus, Trokamed, Nuwellis and Baxter. The early alert notices are part of an FDA pilot program launched in November designed to more quickly inform the public of potential high-risk device issues.

Olympus endoscope infection risk tied to 120 injuries

Olympus recommended healthcare providers stop using an endoscope accessory due to an infection risk linked to reports of 120 injuries and one death, according to a Dec. 23 early alert from the FDA.

The injury reports followed procedures in...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

Continue Reading

 
Topics: FDA, Govt Agencies, Healthcare System, Medical Devices, Safety
Related Articles:
Device industry scrambles as FDA job cuts cause delays
FDA approves first rapid-acting insulin biosimilar for diabetes
Device industry scrambles amid concern FDA layoffs will cause delays
First Insulin Aspart Biosimilar Receives FDA Approval
In FDA job cuts, experts see threat of far-reaching impact

Share This Article